Form 4: Accelerate Diagnostics Director Hany Massarany Reports Stock Unit Vesting

Director Hany Massarany reports the vesting of restricted stock units into common stock of Accelerate Diagnostics.

Summary

• Hany Massarany, a director of Accelerate Diagnostics, Inc., reported a transaction involving restricted stock units.
• On May 29, 2024, 7,894 restricted stock units (RSUs) vested and were converted into common stock.
• The RSUs were granted on May 29, 2023, and vested on the first-year anniversary of the grant date.
• Following the transaction, Massarany directly owns 32,154 shares of common stock and indirectly owns 3,000 shares through the Massarany Family Trust dated November 15, 2012.

Sentiment

Score: 5

Explanation: This is a routine disclosure of stock unit vesting, neither particularly positive nor negative.

Positives

• The vesting of RSUs indicates that Massarany has met certain performance or time-based requirements set by the company.

Industry Context

Form 4 filings are standard disclosures required by the SEC when insiders, such as directors and officers, trade in their company's stock; this provides transparency to the market.

Stakeholder Impact

• The vesting of RSUs increases the number of shares outstanding, which could have a minor dilutive effect on existing shareholders.

Key Dates